Albuminuria is associated with progression of kidney disease and is the accepted gold standard for screening, staging, and prognostication of chronic kidney disease. This review focuses on current literature that has explored applications of albuminuria as a surrogate outcome, variable used in kidney failure risk prediction for novel populations, and variable that may be predicted by other proteinuria measures.

中文翻译：

---

白蛋白尿、蛋白尿和试纸：风险预测中的新关系和效用。

白蛋白尿与肾病的进展有关，是公认的慢性肾病筛查、分期和预后的金标准。本综述重点关注当前文献，这些文献探讨了蛋白尿作为替代结果的应用，用于预测新人群肾衰竭风险的变量，以及可通过其他蛋白尿测量值预测的变量。